Home/Primary Ovarian Insufficiency (POI)
Condition Deep-Dive

Primary Ovarian Insufficiency (POI)

A loss of normal ovarian function before age 40, often presenting as irregular periods, hot flashes and a raised follicle-stimulating hormone (FSH) level. Affects about 1% of women under 40 in older studies and up to 3.5% in recent ones9, with major implications for fertility, bone3, brain and cardiovascular health.

Hormonal & Women's Health Evidence-Based

Last updated:

โš ๏ธ Medication safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside your prescribed treatment, never to replace it. Never stop, reduce or change your hormone treatment, including estrogen, without your prescriber's guidance. Doing so can be dangerous. Several supplements interact with hormone treatment, so talk to your prescriber or pharmacist before starting anything on this page.
Definition

What Is POI?

POI is the loss of normal ovarian function before age 40, due to a decline in egg quantity or quality, or an autoimmune or genetic disruption of follicular activity2. It is not simply "early menopause," because ovarian function in POI can fluctuate, and 4% to 9% of women in two cohorts conceived naturally after diagnosis15.

Diagnosis rests on at least 4 months of irregular or absent periods before 40 and a raised FSH above 25 IU/L: NICE (the UK's National Institute for Health and Care Excellence) asks for two tests 4 to 6 weeks apart, while the 2024 ESHRE (European Society of Human Reproduction and Embryology) guideline accepts one19. AMH (anti-Mรผllerian hormone, a marker of the remaining egg supply) is usually very low or undetectable, and estradiol is often (though not always) low. POI is different from "diminished ovarian reserve," which describes reduced fertility potential but preserved ovulation and cycles.

POI has serious consequences: a sharp drop in fertility and, if untreated, increased fracture risk from accelerated bone loss and higher cardiovascular and cognitive risk from premature estrogen loss. POI has four main categories, each with different implications for treatment and family-building:

The uterus and ovaries surrounded by icons for irregular periods, hot flashes, vaginal dryness and night sweats

Spontaneous / Idiopathic POI

The largest category: in most cases no cause is found7.

  • โ†’Hallmarks: Cycle irregularity, then amenorrhea before age 40 without identified cause
  • โ†’Key supports: HRT, bone-protective nutrition and exercise, and early fertility counseling (CoQ10 4 and N-acetylcysteine, or NAC, are unproven in POI)

Autoimmune POI

About one in five women with POI has an autoimmune disease7, and immune damage to ovarian tissue is one cause, often co-occurring with autoimmune thyroid disease, type 1 diabetes, Addison's disease or polyglandular autoimmune syndromes.

  • โ†’Hallmarks: Other autoimmune diagnoses, lymphocytic oophoritis on biopsy, antibodies to adrenal/​ovarian tissue
  • โ†’Watch-out: Adrenal antibodies and morning cortisol must be checked: missed Addison's is dangerous

Iatrogenic POI (Chemo, Radiation, Surgery)

Caused by ovarian damage from chemotherapy (especially alkylating agents), pelvic radiation or bilateral ovarian surgery. Increasingly common as more young women survive cancer treatment.

  • โ†’Hallmarks: Clear temporal link to chemo, radiation or oophorectomy
  • โ†’Primary lever: Fertility preservation before treatment if possible (egg/embryo freezing, ovarian tissue cryopreservation)
  • โ†’Key supports: HRT (oncology-cleared), bone-and-heart-protective nutrition

Genetic POI (FMR1, Turner Variants, Other)

Genetic conditions cause as much as 28% of POI7, including FMR1 premutations (Fragile X-associated POI), Turner syndrome variants (45,X mosaics, structural X abnormalities) and other rare gene mutations.

  • โ†’Hallmarks: Family history of POI, fragile X-associated tremor/​ataxia syndrome (FXTAS) or intellectual disability
  • โ†’Primary lever: Karyotype + FMR1 testing + genetic counseling for family planning
  • โ†’Key supports: HRT, donor-egg counseling if conception desired, bone & cardiovascular protection
By the Numbers

POI by the Numbers

1% to 3.5%
of women develop POI before 40 without a medical cause: about 1% in older studies, up to 3.5% in recent ones9
10 per 100,000
women aged 15 to 29 have a natural menopause each year, against 76 per 100,000 at 30 to 39, in a US cohort of 1,858 women whose risk by 40 was 1%16
4% to 9%
conceived naturally after a POI diagnosis in two referral-center cohorts of 358 and 324 women, because ovarian activity can return15
~1 in 5
women with POI have an autoimmune disease, most often thyroiditis7
Up to 28%
of cases are caused by genetic conditions, such as a fragile X premutation or Turner syndrome7
10% to 20%
of women with POI have a family history of it7
Signs & Symptoms

Symptoms of POI

POI shows up as menopause-like symptoms appearing decades early, plus the emotional impact of an unexpected fertility limitation.

SymptomWhat happens
Reproductive & Hormonal Symptoms
Irregular, Skipped or Absent PeriodsCycles that lengthen, skip or stop entirely before age 40. May follow a "perimenopause-like" pattern of unpredictability, or stop abruptly after coming off contraception.
Infertility / Difficulty ConceivingOften the presenting concern. Low AMH and high FSH usually reveal the diagnosis, although intermittent ovulation means spontaneous conception is still occasionally possible.
Vaginal Dryness & DyspareuniaLow estrogen thins vaginal tissue and reduces natural lubrication, causing burning, irritation and painful intercourse.
Low LibidoReduced sexual desire and arousal driven by lower estrogen and testosterone production. Often layered with body-image and relationship grief5 tied to the diagnosis.
Accelerated Bone LossEstrogen is the primary brake on bone resorption. POI without HRT substantially raises osteoporosis and fracture risk. Bone-density (DXA) testing is part of the standard POI workup.
Elevated Cardiovascular RiskPOI raises the risk of heart disease and stroke, and without hormone therapy it is linked to shorter life expectancy, largely through cardiovascular disease8.
Vasomotor, Systemic & Psychological Symptoms
Hot Flashes & Night SweatsSudden flushing, sweating and palpitations triggered by estrogen withdrawal. In POI, these can appear in the teens, 20s or 30s and are often dismissed as "stress" or anxiety until FSH is checked.
Insomnia & Sleep FragmentationDifficulty falling asleep and staying asleep, and frequent night sweats.
Brain Fog & Memory ChangesWord-finding difficulty, lost trains of thought and slower processing. POI is linked to a higher risk of cognitive impairment and dementia, one reason hormone therapy is recommended8.
Anxiety, Depression & Mood LabilityBoth the biological effect of estrogen loss and the psychological impact of fertility loss feed into elevated rates of anxiety and depression.
Joint Pain & StiffnessPOI often causes new-onset stiffness, particularly morning stiffness, that can be misread as early rheumatologic disease.
Fatigue & Reduced StaminaPervasive fatigue layered on poor sleep, hormonal shifts and the emotional weight of the diagnosis. Worth screening for coexisting thyroid disease, adrenal insufficiency and iron deficiency, all over-represented in POI.
โš ๏ธ Pattern to watch for: In any woman under 40 with skipped or absent periods plus hot flashes, night sweats, vaginal dryness or new-onset insomnia, ask for an FSH test; guidelines differ on whether one raised result is enough or a second, 4 to 6 weeks later, is needed9. POI is frequently missed for years and the cost of delayed diagnosis (bone, brain, heart) is high.
Causes

Causes of POI

In most cases no cause is found7. The causes that are known change the tests, the advice for relatives and sometimes the treatment.

CauseHow It Contributes to POIWhat Helps
Genetic and chromosomal conditionsGenetic conditions cause as much as 28% of cases; a fragile X premutation raises the risk, and most women with Turner syndrome develop POI7Chromosome analysis and fragile X premutation testing for everyone whose POI was not caused by treatment, and genetic counseling and testing for relatives when a genetic cause is found9
Autoimmune diseaseAbout one in five women with POI has an autoimmune disease, most often thyroiditis; Addison's disease is also linked7Adrenal (21-⁠hydroxylase) antibody screening when the cause is unknown, with referral for adrenal testing if it is positive, and a thyroid (TSH) check at diagnosis and every 5 years9
Cancer treatment and ovarian surgeryChemotherapy and radiation therapy can damage follicle cells7, and surgery to remove the ovaries causes menopause directly17Counseling about POI risk and fertility preservation before treatment, then hormone therapy afterward unless a hormone-dependent cancer rules it out8
Family historyAbout 10% to 20% of women with POI have a family history of it7, and sisters and daughters of women whose POI was not caused by treatment are at higher risk9Telling relatives, who may want to consider family planning and fertility preservation; there is no proven way to predict or prevent POI9
Smoking, chemicals and some infectionsCigarette smoke, chemicals and pesticides can speed up the loss of follicles, and some viruses affect follicle function7; current smokers have about twice the risk of menopause before 40 18Stopping smoking; the 2024 guideline lists smoking among the modifiable risk factors9
Diagnosis

How POI Is Diagnosed

Diagnosis is built on at least 4 months of irregular or absent periods before 40 and a raised FSH (greater than 25 IU/L): NICE asks for two samples 4 to 6 weeks apart, while the 2024 ESHRE guideline accepts one and repeats it when in doubt9. Genetic and autoimmune workup follow.

TestWhat it shows
At-Home Screening
Cycle & Symptom TrackingLog cycle length, period flow, hot flashes, night sweats, vaginal dryness, sleep quality and mood for at least 3 cycles. Cycles that lengthen by more than a week, skip entirely or show menopause-like symptoms in your 20s or 30s warrant an FSH test.
Family History AuditCheck for relatives with early menopause (before 45), POI, fragile X syndrome, fragile X-associated tremor/​ataxia, autoimmune diseases (Hashimoto's, type 1 diabetes, Addison's) or unexplained infertility.
Lab & Clinical Tests
FSH, LH & Estradiol (Two Draws, 4 to 6 Weeks Apart)FSH greater than 25 IU/L on two separate occasions, drawn 4 to 6 weeks apart (NICE; the 2024 ESHRE guideline accepts one), in the setting of oligo- or amenorrhea in a woman under 40, defines POI. Estradiol is usually low (less than 50 pg/mL) but can fluctuate. The FSH test does not need to be timed to a cycle day9.
AMH (Anti-Mรผllerian Hormone)Reflects remaining follicle pool. NICE advises against using it routinely for diagnosis; it helps when the diagnosis is uncertain9.
Karyotype & FMR1 PremutationKaryotype identifies Turner syndrome variants and other X-chromosome anomalies. FMR1 CGG repeat number identifies fragile X premutation carriers, important for family planning and the risk of fragile X-associated tremor/​ataxia syndrome (FXTAS) later in life.
Autoimmune PanelTSH, free T4, 21-⁠hydroxylase antibodies, morning cortisol, ACTH stimulation if indicated, fasting glucose, HbA1c, ANA; TPO & thyroglobulin antibodies only if indicated. The 2024 guideline advises adrenal antibodies when the cause is unknown and TSH at diagnosis and every 5 years, but not routine TPO antibodies9.
Bone Density & Cardiovascular WorkupDXA scan at baseline; lipid panel, fasting glucose, hs-CRP, vitamin D, calcium, PTH. If the scan is normal and hormone therapy is taken as prescribed, a repeat within 5 years adds little; low bone density is rechecked every 1 to 3 years10.
Transvaginal Pelvic UltrasoundLooks for ovarian volume and antral follicle count (AFC). Also rules out structural causes of amenorrhea (uterine anomalies, ovarian masses).
Treatment Comparison

Conventional and Holistic Treatment for POI

POI is one of the conditions where holistic and conventional approaches are most clearly complementary: hormone replacement is generally indicated until the natural age of menopause (~51), with supportive care layered on top for bone, heart and mood.

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Layer onto appropriate HRT, protect bone and heart, support mood and sleep

Primary Focus
Bone-protective and heart-healthy nutrition, exercise and mental health care
Duration
Lifelong lifestyle integration; intensive 6 to 12-⁠month protocol around diagnosis
Effect on Underlying Disorder
Does not restore ovarian function or replace lost follicles
Fertility Outcome
4% to 9% conceived naturally in two cohorts15; supplements have not been shown to improve this

Full Holistic Approach Includes

  • Anti-inflammatory, Mediterranean-pattern whole-food eating with adequate calcium, vitamin D, magnesium and protein
  • Strength training 2 to 4x per week plus weight-bearing cardio, foundational for bone preservation
  • Antioxidant supplements such as CoQ10 and NAC have not been shown to help in POI, and none replaces hormone therapy8
  • Treat coexisting autoimmune disease; test for celiac disease before any gluten change; keep vitamin D and omega-⁠3 intake adequate
  • Sleep optimization: a cool sleep environment for hot flashes at night, and magnesium for sleep (a trial found it did not reduce hot flashes)
  • Stress and HPA-axis work, breathwork, vagal tone, meditation, therapy
  • Mental health support, fertility counseling, peer support, grief work
  • Endocrine-disruptor reduction, replace plastic, fragrance-free personal care, filter water
โš ๏ธ Side effects: Minimal when supplements are properly chosen and dosed. The largest risk is using "natural" approaches alone in place of HRT, which leaves bone, brain and cardiovascular tissue unprotected until the natural age of menopause. Holistic care belongs alongside HRT, not instead of it.
Supplement Protocol

Evidence-Based Supplements for POI

No supplement has been shown to improve ovarian function in POI, and the evidence for most is insufficient8. They are not a substitute for HRT. Coordinate with your physician, especially if you are on hormone replacement.

Supplement What it is for Typical range Timing Notes & cautions
Coenzyme Q10 (Ubiquinol)Studied mainly for egg quality in poor ovarian response, not in POI, and not shown to improve conception in POI4200 to 600 mg ubiquinol per dayWith a fat-containing meal, morning preferredNot shown to help POI, or to improve ovarian function or conception. Ubiquinol is the more bioavailable form.
Vitamin D3 (with K2)Needed for bone; the 2024 guideline advises calcium and vitamin D where vitamin D status or calcium intake is inadequate10.D3: test 25-⁠OH-D first and set the dose with your clinician; K2 (MK-⁠7): 100 to 200 mcg per dayWith a fat-containing meal, morning preferredTest 25-⁠OH-D. The adult upper limit is 4,000 IU (100 mcg) a day12. If you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonizes warfarin, and changing your intake destabilizes the INR. Consistency matters more than avoidance. This does not apply in the same way to direct oral anticoagulants such as apixaban or rivaroxaban, but tell your prescriber about any supplement you take.
Calcium (with Magnesium & K2)Bone-mineralization foundation, especially important when HRT alone may not fully protect bone.1,000 to 1,200 mg/day from food + supplement combinedSplit doses, with mealsFood-first; supplement only if dietary calcium falls below 1,000 mg/day. Avoid more than 500 mg in a single dose. The upper limit is 2,500 mg a day from food and supplements together12.
Magnesium GlycinateUsed for sleep; a placebo-controlled trial found magnesium did not reduce hot flashes13.300 to 500 mg elemental magnesium per dayEvening, 30 to 60 min before bedMagnesium oxide is poorly absorbed. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Omega-⁠3 EPA/DHAReduces inflammation, supports cardiovascular health, brain function and mood.2 to 3 g combined EPA+DHA per dayWith mealsChoose a third-party-tested product. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day23, so check this dose with your clinician first.
SeleniumRequired for glutathione peroxidase and thyroid function.100 to 200 mcg per dayWith foodTwo Brazil nuts per day is a food alternative, but their selenium content varies widely, so do not combine them with a daily supplement. In trials, selenium supplements slightly raised the risk of type 2 diabetes24. Do not exceed 400 mcg a day from all sources25.
ZincRequired for ovulation, immune function and bone metabolism. Often low in restrictive eating patterns.15 to 30 mg per dayWith mealsAdd 1 to 2 mg copper if using more than 8 weeks at higher doses.
B-ComplexSupports methylation, neurotransmitter balance and homocysteine metabolism. Particularly relevant for mood, sleep and cardiovascular protection.1 capsule per day per product labelMorning with foodStandard or methylated forms both work for most people.
Black CohoshA Cochrane review of 16 trials found no difference from placebo in hot flash frequency; sometimes tried by women who cannot use HRT14.Not recommended for hot flashes (16 trials found no difference from placebo)Not applicableAvoid in liver disease. Rare cases of serious liver damage have been reported: stop it and see a clinician for dark urine or unusual fatigue. May not be safe in pregnancy or breastfeeding14.
Multi-Strain ProbioticMay help general gut symptoms; evidence in POI is lacking.25 to 50 billion CFU per day, multi-strainEmpty stomach or with light mealUse caution with immunosuppression or a central line; discuss with your team.
What to Expect

What to Expect Over Time

POI is long term; hormone replacement is the main treatment, with checks on bone, heart and mood.

Treatment and supportive care, together
First Weeks

Diagnosis needs at least 4 months of irregular or absent periods and a raised FSH, repeated if in doubt9. A bone density scan is recommended at diagnosis10. Pregnancy is still possible and HRT is not a contraceptive, so use contraception if you want to avoid it11.

Months 1 to 3

Hormone replacement is recommended until the usual age of menopause, with or without symptoms, to protect bone, heart and brain; NICE offers HRT or a combined hormonal contraceptive8. Psychological support is offered to everyone8.

Months 3 to 12

No treatment has been shown to raise the chance of natural conception; egg donation is an established option, and adoption and surrogacy are others11. Calcium and vitamin D are added if intake or levels are low10.

Long Term

Without hormone therapy, POI is linked to shorter life expectancy, largely through heart disease8. A normal bone scan on hormone therapy needs no repeat within 5 years; low bone density is rechecked every 1 to 3 years10. At the usual age of menopause, continuing is reviewed8.

When to Seek Care

Call 911 for chest pain or breathlessness, especially with a painful, swollen leg, which can mean a blood clot, a small risk with HRT19. With Addison's disease, call 911 if symptoms suddenly worsen with vomiting, severe abdominal pain, marked dizziness, drowsiness or confusion: these can be adrenal crisis20. See a doctor for bleeding on HRT beyond 6 months21. For thoughts of suicide, call or text 988 in the US, or call 911 if you are in immediate danger22.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Hormone Replacement Protects Bone and Heart

POI is long term, and hormone replacement until the usual age of menopause is standard care rather than an optional extra. Nutrition works alongside it, never in place of it, with checks on bone, heart and mood. Nothing on this page restores ovarian function.

Explore Menopause โ†’ Explore Turner Syndrome โ†’

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.6 The most consequential thing on this page is that under-treatment is the harm here, not over-treatment. Primary ovarian insufficiency before the usual age of menopause means decades of estrogen deficiency, and that carries real risks to bone, cardiovascular and cognitive health. Hormone replacement until around the average age of natural menopause, roughly 51, is standard care rather than an optional extra, and the risk calculus is completely different from hormone therapy started after a normal menopause. If you have been told to avoid HRT because of what you have read about menopause hormone therapy, that advice does not transfer to POI and is worth revisiting with a specialist. Nothing on this page restores ovarian function.

  1. On diagnosis: POI is defined by amenorrhea or oligomenorrhea before age 40 with a raised FSH, on two occasions 4 to 6 weeks apart in NICE guidance, or once in the 2024 guideline unless there is doubt. It affects roughly 1% to 3.5% of women. It is not early menopause: ovarian function fluctuates, follicles can be present, and spontaneous ovulation and pregnancy occur in a minority, reported at 4.4% and 8.6% in two referral-center cohorts. ↩
  2. On causes: most cases are idiopathic. Identifiable causes include Turner syndrome and other X-chromosome abnormalities, FMR1 premutation (fragile X), autoimmune oophoritis often with adrenal or thyroid autoimmunity, and iatrogenic causes including chemotherapy, pelvic radiation therapy and oophorectomy. Karyotype, FMR1 testing and adrenal antibody testing are standard, and fragile X carrier status has implications for relatives. ↩
  3. On bone: bone density should be assessed, and calcium, vitamin D and weight-bearing plus resistance exercise matter, but none of these substitutes for estrogen in a young woman with POI. Estrogen deficiency is the driver, and replacing it is the intervention that protects the skeleton. ↩
  4. On fertility: spontaneous conception remains possible and contraception is still needed if pregnancy is not wanted. There is no intervention shown to restore ovarian function or reliably improve natural conception rates in POI, including DHEA, growth hormone and CoQ10, which have been studied mainly in poor ovarian response rather than in POI. Donor oocyte IVF has high success rates and should be discussed early rather than after years of supplements. ↩
  5. On the psychological impact: a POI diagnosis in a young woman frequently arrives alongside grief about fertility and identity, and it is under-supported. This is a legitimate part of care rather than an afterthought. ↩
  6. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩
  7. On causes: the NIH child health institute says that in most cases the cause of POI is unknown. About 10% to 20% of women with POI have a family history of it, and genetic conditions cause as much as 28% of cases, including a fragile X premutation; most women with Turner syndrome develop POI. Several studies suggest about one fifth of women with POI have an autoimmune disease, most often thyroiditis; Addison's disease is also linked. Chemotherapy and radiation therapy can damage follicle cells, cigarette smoke, chemicals and pesticides can speed up follicle loss, and some viruses affect follicle function, NICHD, what causes POI and NICHD, about POI. ↩
  8. On hormone therapy: the 2024 international guideline recommends hormone therapy for women with POI until the usual age of menopause, whether or not they have symptoms, to reduce illness and death. POI without it is linked to shorter life expectancy (largely through cardiovascular disease) and to higher risks of heart disease, stroke, osteoporosis, fracture, cognitive impairment and dementia. It found no evidence that hormone therapy raises breast cancer risk above that of women the same age without POI, advises avoiding it with hormone-dependent ovarian or uterine tumors, suggests at least 2 mg a day of estrogen by mouth or 100 micrograms a day through the skin for bone, recommends at least yearly checks of blood pressure, weight and smoking, offers psychological assessment to all, and reviews the need to continue at the usual age of menopause. Complementary therapies should not replace hormone therapy, and there is insufficient evidence for other nutrient supplements and herbal medicines. NICE advises offering HRT or a combined hormonal contraceptive, unless contraindicated, until at least the age of natural menopause, notes that baseline risks of breast cancer and cardiovascular disease are very low under 40 and that both options protect bone, and reminds that HRT is not a contraceptive, PubMed 39660328 and NICE NG23. ↩
  9. On diagnosis and testing: the 2024 international guideline (ESHRE with the American Society for Reproductive Medicine and others) diagnoses POI from at least 4 months of absent or irregular periods with an FSH above 25 IU/L, repeated after 4 to 6 weeks if there is doubt and not timed to a cycle day, and puts prevalence at about 1% in older studies and 3.5% in recent ones. NICE asks for a raised FSH on 2 samples 4 to 6 weeks apart and advises against diagnosing on a single test or routinely using AMH. The guideline recommends chromosome analysis and fragile X premutation testing for all women whose POI was not caused by treatment, 21-⁠hydroxylase antibody screening when the cause is unknown with referral for adrenal testing if positive, TSH at diagnosis and every 5 years, not routine TPO antibody testing, and genetic counseling and testing for relatives when a genetic cause is found. Sisters and daughters are at higher risk, there is no proven way to predict or prevent POI, and smoking is among the modifiable risk factors, PubMed 39660328 and NICE NG23. ↩
  10. On bone: the 2024 international guideline recommends a bone density (DXA) scan at diagnosis for all women with POI where available. If it is normal and hormone therapy is taken as prescribed, a repeat within 5 years adds little; low bone density or osteoporosis is reassessed every 1 to 3 years. Calcium and vitamin D supplements may be needed when vitamin D status or calcium intake is inadequate, alongside weight-bearing exercise, a healthy diet, not smoking and a normal body weight, and hormone therapy is recommended to maintain bone density, PubMed 39660328. ↩
  11. On fertility: the 2024 international guideline says POI substantially reduces the chance of natural conception, but ovarian activity and pregnancy can still occur, so contraception is advised if pregnancy is not wanted; no intervention has been reliably shown to increase ovarian activity or natural conception rates; and egg donation is an established option, with those pregnancies managed as high risk. NHS guidance also lists IVF with a woman's own previously frozen eggs, surrogacy and adoption, PubMed 39660328 and NHS, early menopause. ↩
  12. On upper limits: the tolerable upper intake level for calcium, counting food and supplements together, is 2,500 mg a day for adults aged 19 to 50 and 2,000 mg a day from 51, Linus Pauling Institute, calcium; for vitamin D it is 4,000 IU (100 micrograms) a day for adults, Linus Pauling Institute, vitamin D. ↩
  13. On magnesium and hot flashes: in a placebo-controlled trial of 289 postmenopausal women with a history of breast cancer, magnesium oxide at 800 or 1,200 mg a day did not reduce hot flashes and caused more diarrhea, PubMed 25423327. ↩
  14. On black cohosh: a 2012 Cochrane review of 16 trials in 2,027 perimenopausal and postmenopausal women found no difference from placebo in hot flash frequency, PubMed 22972105. The NIH complementary health center reports rare cases of liver damage, some very serious, advises contacting a clinician for symptoms such as dark urine and fatigue, and says it may not be safe in pregnancy or breastfeeding, NCCIH, black cohosh. ↩
  15. On natural pregnancy after diagnosis: of 358 women with POI of unknown cause followed at a referral center, 24% showed signs of ovarian function returning (mostly within a year of diagnosis) and 4.4% had a natural pregnancy, PubMed 21994953; in a survey of 324 women with POI at a Paris referral center, excluding Turner syndrome and POI after cancer treatment, 8.6% had a natural pregnancy, and more than half of those who went on to have children did so by egg donation, PubMed 36763040. ↩
  16. On how often POI occurs by age: in a cohort of 1,858 women from Rochester, Minnesota, followed for the date of menopause, the yearly rate of natural menopause was 10 per 100,000 at ages 15 to 29 and 76 per 100,000 at 30 to 39, and the risk of natural menopause by age 40 was 1%, PubMed 3960433. ↩
  17. On early menopause: NHS guidance says early menopause can be caused by radiation therapy, chemotherapy, certain hormone medicines or surgery to remove the ovaries, and is more likely with a family history, early first periods, smoking or being underweight; replacing hormones matters when menopause starts before 45 because of higher risks to bones and heart, NHS, early menopause. ↩
  18. On smoking: pooled data from 17 studies of 207,231 women found that current smokers had about twice the risk of premature (before 40) and early (40 to 44) menopause, with risk rising with the years smoked; women who had quit more than 10 years earlier had a risk similar to never smokers, PubMed 30481189. ↩
  19. On blood clots: NHS guidance lists taking HRT or estrogen-containing contraception among the things that make a deep vein thrombosis more likely, and advises emergency care for leg pain and swelling with breathlessness or chest pain, because the clot can travel to the lungs, NHS, DVT. ↩
  20. On adrenal crisis: NHS guidance advises calling emergency services if someone with Addison's disease has symptoms that suddenly get worse, such as a fast heart rate, severe dizziness on standing, severe belly or side pain, vomiting, drowsiness, irritability or confusion, a seizure or loss of consciousness, even after an emergency steroid injection, NHS, Addison's disease. ↩
  21. On HRT side effects: NHS guidance says irregular bleeding is common in the first months of HRT and usually settles within 6 months, and advises seeing a doctor if it lasts more than 6 months, becomes heavier or starts after periods had stopped; HRT carries a small increase in the risk of blood clots and breast cancer, NHS, side effects of HRT. ↩
  22. On crisis help: NIMH advises anyone struggling or having thoughts of suicide to call or text the 988 Suicide and Crisis Lifeline at 988, and to call 911 in life-threatening situations, NIMH, suicide prevention. ↩
  23. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
  24. Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018;1(1):CD005195. PubMed 29376219. In randomized trials at low risk of bias, selenium supplements did not change the incidence of any cancer (risk ratio 1.01); across the trials, supplementation slightly raised the risk of type 2 diabetes. ↩
  25. On the selenium upper limit: the tolerable upper intake level for adults 19 and older is 400 micrograms a day; a single Brazil nut grown in selenium-rich soil may provide more than 100 micrograms, Linus Pauling Institute, selenium. ↩